Post-surgical Inflammation Clinical Trial
Official title:
Tobradex BID Compared to TOBRADEX and TOBREX/Vehicle
The purpose of this study is to compare the new formulation of Tobradex to the current approved formulation
n/a
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03521791 -
Efficacy and Safety of PRO-155 on Inflammation of the Conjunctival Surface in Subjects With Grade I-III Pterygium vs Placebo.
|
Phase 4 |